Comparison of Therapeutic Effects of Garlic and d-Penicillamine in Patients with Chronic Occupational Lead Poisoning

Basic and Clinical Pharmacology and Toxicology

Volumn 110, Issue 5, 2012, Pages 476-481

  Kianoush, Sina ^a   Balali Mood, Mahdi ^a   Mousavi, Seyed Reza ^a   Moradi, Valiollah ^a   Sadeghi, Mahmoud ^a   Dadpour, Bita ^a   Rajabi, Omid ^b   Shakeri, Mohammad Taghi ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALLICIN; GARLIC EXTRACT; GRAPHITE; LEAD; PENICILLAMINE;

ABDOMINAL PAIN; ADULT; ANOREXIA; APPETITE; ARTHRALGIA; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BATTERY INDUSTRY; DENTAL CARIES; DIASTOLIC BLOOD PRESSURE; DISTAL PARESTHESIA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; EUPHORIA; FATIGUE; GASTROINTESTINAL SYMPTOM; HALITOSIS; HAND PARESTHESIA; HEADACHE; HUMAN; IRRITABILITY; LEAD BLOOD LEVEL; LEAD POISONING; LOW BACK PAIN; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MOUTH ULCER; MYALGIA; NEBULIZATION; POLYURIA; PRIORITY JOURNAL; RANDOMIZATION; SIDE EFFECT; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; TENDON REFLEX; THORAX PAIN; TREATMENT DURATION; WEIGHT REDUCTION;

ADULT; ANTIOXIDANTS; CHELATING AGENTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; GARLIC; HUMANS; LEAD POISONING; MALE; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PENICILLAMINE; PLANT EXTRACTS; PROSPECTIVE STUDIES;

ALLIUM SATIVUM; ANIMALIA;

EID: 84859863574     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00841.x     Document Type: Article

References (50)

1. Hernberg S. Lead poisoning in a historical perspective. Am J Ind Med 2000;38:244-54.
2. Amundsen T, Naess IA, Hammerstrom J, Brudevold R, Bjerve KS. Lead poisoning - an overview. Tidsskr Nor Laegeforen 2002;122:1473-6.
3. Needleman H. Low level lead exposure: history and discovery. Ann Epidemiol 2009;19:235-8.
4. Telisman S, Colak B, Pizent A, Jurasovic J, Cvitkovic P. Reproductive toxicity of low-level lead exposure in men. Environ Res 2007;105:256-66.
5. Chiado LM, Jacobson SW, Jacobson JL. Neurodevelopment effects of postnatal lead exposure at very low levels. Neurotoxicol Teratol 2004;26:359-71.
6. Hoet P, Buchet JP, Decerf L, Lavalleye B, Haufroid V, Lison D. Clinical evaluation of a lead mobilization test using the chelating agent dimercaptosuccinic acid. Clin Chem 2006;52:88-96.
7. Koller K, Brown T, Spurgeon A, Levy L. Recent developments in low-level lead exposure and intellectual impairment in children. Environ Health Perspect 2004;112:987-94.
8. Campbell JR, Rosier RN, Novotny L, Puzas JE. The association between environmental lead exposure and bone density in children. Environ Health Perspect 2004;112:1200-3.
9. Bellinger DC. Lead. Pediatrics 2004;113:1016-22.
10. Pearce JM. Burton's line in lead poisoning. Eur Neurol 2007;57:118-9.
11. Kosnett MJ, Wedeen RP, Rothenberg SJ, Hipkins KL, Materna BL, Schwartz BS et al. Recommendations for medical management of adult lead exposure. Environ Health Perspect 2007;115:463-71.
12. Patrick L. Lead toxicity, a review of the literature. Part 1: exposure, evaluation, and treatment. Altern Med Rev 2006;11:2-22.
13. Malekirad AA, Oryan S, Fani A, Babapor V, Hashemi M, Baeeri M et al. Study on clinical and biochemical toxicity biomarkers in a zinc-lead mine workers. Toxicol Ind Health 2010;26:331-7.
14. Cohen SM. Lead poisoning: a summary of treatment and prevention. Pediatr Nurs 2001;27:125-6.
15. Blanusa M, Varnai VM, Piasek M, Kostial K. Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem 2005;12:2771-94.
16. Chisolm JJ Jr. BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children. J Toxicol Clin Toxicol 1992;30:493-504.
17. Klaassen CD, Waalkes MP, Cantilena LR Jr. Alteration of tissue disposition of cadmium by chelating agents. Environ Health Perspect 1984;54:233-42.
18. Llobet JM, Domingo JL, Corbella J. Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion and distribution of cobalt. Arch Toxicol 1986;58:278-81.
19. Kalia K, Flora SJ. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. J Occup Health 2005;47:1-21.
20. Rush T, Hjelmhaug J, Lobner D. Effects of chelators on mercury, iron, and lead neurotoxicity in cortical culture. Neurotoxicology 2009;30:47-51.
21. Denver MC, Tell LA, Galey FD, Trupkiewicz JG, Kass PH. Comparison of two heavy metal chelators for treatment of lead toxicosis in cockatiels. Am J Vet Res 2000;61:935-40.
22. Massadeh AM, Al-Safi SA, Momani IF, Alomary AA, Jaradat QM, AlKofahi AS. Garlic (Allium sativum L.) as a potential antidote for cadmium and lead intoxication: cadmium and lead distribution and analysis in different mice organs. Biol Trace Elem Res 2007;120:227-34.
23. Pourjafar M, Aghbolaghi PA, Shakhse-Niaie M. Effect of garlic along with lead acetate administration on lead burden of some tissues in mice. Pak J Biol Sci 2007;10:2772-4.
24. Senapati SK, Dey S, Dwivedi SK, Swarup D. Effect of garlic (Allium sativum L.) extract on tissue lead level in rats. J Ethnopharmacol 2001;76:229-32.
25. Hanafy MS, Shalaby SM, El-Fouly MA, Abd El-Aziz MI, Soliman FA. Effect of garlic on lead contents in chicken tissues. Dtsch Tierarztl Wochenschr 1994;101:157-8.
26. Shahsavani D, Baghshani H, Alishahi E. Efficacy of allicin in decreasing lead (Pb) accumulation in selected tissues of lead-exposed common Carp (Cyprinus carpio). Biol Trace Elem Res 2011;142:572-80.
27. Najar-Nezhad V, Aslani MR, Balali-Mood M. Evaluation of allicin for the treatment of experimentally induced subacute lead poisoning in sheep. Biol Trace Elem Res 2008;126:141-7.
28. Chaudhuri BN, Mukherjee SK, Mongia SS, Chakravarty SK. Hypolipidemic effect of garlic and thyroid function. Biomed Biochim Acta 1984;43:1045-7.
29. Goncagul G, Ayaz E. Antimicrobial effect of garlic (Allium sativum). Recent Pat Antiinfect Drug Discov 2010;5:91-3.
30. Ngo SN, Williams DB, Cobiac L, Head RJ. Does garlic reduce risk of colorectal cancer? A systematic review J Nutr 2007;137:2264-9.
31. Fukao H, Yoshida H, Tazawa Y, Hada T. Antithrombotic effects of odorless garlic powder both in vitro and in vivo. Biosci Biotechnol Biochem 2007;71:84-90.
32. Asdaq SM, Inamdar MN. The potential benefits of a garlic and hydrochlorothiazide combination as antihypertensive and cardioprotective in rats. J Nat Med 2011;65:81-8.
33. Gorinstein S, Leontowicz H, Leontowicz M, Drzewiecki J, Najman K, Katrich E et al. Raw and boiled garlic enhances plasma antioxidant activity and improves plasma lipid metabolism in cholesterol-fed rats. Life Sci 2006;78:655-63.
34. Netter P, Bannwarth B, Pere P, Nicolas A. Clinical pharmacokinetics of d-penicillamine. Clin Pharmacokinet 1987;13:317-33.
35. American Academy of Pediatrics, Committee on Drugs. Treatment guidelines for lead exposure in children. Pediatrics 1995;96:155-60.
36. Naarala JT, Loikkanen JJ, Ruotsalainen MH, Savolainen KM. Lead amplifies glutamate-induced oxidative stress. Free Radic Biol Med 1995;19:689-93.
37. Wang J, Wu J, Zhang Z. Oxidative stress in mouse brain exposed to lead. Ann Occup Hyg 2006;50:405-9.
38. Wang L, Wang H, Li J, Chen D, Liu Z. Simultaneous effects of lead and cadmium on primary cultures of rat proximal tubular cells: interaction of apoptosis and oxidative stress. Arch Environ Contam Toxicol 2011;61:500-11.
39. Liu MY, Cheng YJ, Chen CK, Yang BC. Coexposure of lead- and lipopolysaccharide-induced liver injury in rats: involvement of nitric oxide-initiated oxidative stress and TNF-alpha. Shock 2005;23:360-4.
40. El-Ashmawy IM, Ashry KM, El-Nahas AF, Salama OM. Protection by turmeric and myrrh against liver oxidative damage and genotoxicity induced by lead acetate in mice. Basic Clin Pharmacol Toxicol 2006;98:32-7.
41. Karimooy HN, Mood MB, Hosseini M, Shadmanfar S. Effects of occupational lead exposure on renal and nervous system of workers of traditional tile factories in Mashhad (northeast of Iran). Toxicol Ind Health 2010;26:633-8.
42. Balali-Mood M, Shademanfar S, Rastegar Moghadam J, Afshari R, Namaei Ghassemi M, Allah Nemati H et al. Occupational lead poisoning in workers of traditional tile factories in Mashhad, Northeast of Iran. Int J Occup Environ Med 2010;1:29-38.
43. Iberl B, Winkler G, Muller B, Knobloch K. Quantitative determination of allicin and alliin from garlic by HPLC*. Planta Med 1990;56:320-6.
44. Chung LY. The antioxidant properties of garlic compounds: allyl cysteine, alliin, allicin, and allyl disulfide. J Med Food 2006;9:205-13.
45. Prasad K, Laxdal VA, Yu M, Raney BL. Antioxidant activity of allicin, an active principle in garlic. Mol Cell Biochem 1995;148:183-9.
46. Aslani MR, Najarnezhad V, Mohri M. Individual and combined effect of meso-2, 3-dimercaptosuccinic acid and allicin on blood and tissue lead content in mice. Planta Med 2010;76:241-4.
47. Patrick L. Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev 2006;11:114-27.
48. Shannon MW, Townsend MK. Adverse effects of reduced-dose d-penicillamine in children with mild-to-moderate lead poisoning. Ann Pharmacother 2000;34:15-8.
49. Adelman HM, Winters PR, Mahan CS, Wallach PM. D-penicillamine-induced myasthenia gravis: diagnosis obscured by coexisting chronic obstructive pulmonary disease. Am J Med Sci 1995;309:191-3.
50. Stein HB, Patterson AC, Offer RC, Atkins CJ, Teufel A, Robinson HS. Adverse effects of d-penicillamine in rheumatoid arthritis. Ann Intern Med 1980;92:24-9.